YOLFTbeta
30

Hainan Honz Pharmaceutical Co

300086 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

4.75CNY-0.11 (-2.26%)

Price History

Full chart

Market Stats

Previous Close4.86
Open4.84
Day Range4.74 – 4.88
52-Week Range5.25 – 15.19
Volume10.43M
Market Cap2.44B
P/E (TTM)0.00
Forward P/E45.25
EPS-0.46
Dividend Yield0.00%
Beta0.27
50-Day Avg6.39
200-Day Avg7.91

About

Honz Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pediatric medicines in China and internationally. It operates through Pharmaceutical Manufacturing and Sales; and Daily Necessities Manufacturing and Sales segments. The company offers medicines for children and adults in the areas of anti-anaphylaxis, antidiarrheal, cough relief, anti-flu, antipyretic-analgesic, anti-infection, anti-fungal, endocrine, anti-allergy, antibacterial and antiviral, respiratory system, digestive system, and gynecological indications, as well as nutritional supplements. It also provides maternal and infant health products; protective and medical masks; and medical devices, including medical protective equipment. In addition, the company engages in investment, property, planting, internet sales, and leasing activities. It markets its products through pharmaceutical distribution agents, sales terminals, and a marketing network. The company was formerly known as HaiNan Honz Pharmaceutical Co.,Ltd. and changed its name to Honz Pharmaceutical Co., Ltd. in November 2016. Honz Pharmaceutical Co., Ltd. was founded in 1993 and is headquartered in Haikou, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMs. Liping Hong
  • Employees540
  • HeadquartersNo. 6, Yaogu Third Road, Haikou, China, 570311, China
  • Websitehttps://www.honz.com.cn

Leadership

  • Ms. Liping HongVice Chairman & VP · b. 1968
  • Mr. Dexin LinVP & Board Secretary · b. 1980
  • Mr. Yong WangVice President · b. 1977
  • Mr. Jiangyou HongChairman & President · b. 1964
  • Ms. Jing LiCFO & Accounting Supervisor · b. 1982

Financials

Income Statement

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue95.94M135.85M218.78M314.45M304.24M368.78M309.34M408.54M409.76M471.47M668.14M882.74M1.01B921.64M836.57M535.75M739.57M472.82M466.12M
Growth (%)-+41.59%+61.05%+43.73%-3.25%+21.21%-16.12%+32.07%+0.30%+15.06%+41.71%+32.12%+14.24%-8.61%-9.23%-35.96%+38.05%-36.07%-1.42%
Cost of Revenue39.17M49.50M62.06M101.34M187.68M210.72M165.49M197.72M209.62M277.84M392.50M493.05M534.19M451.93M418.41M269.35M298.27M225.36M213.48M
Gross Profit56.77M86.34M156.72M213.12M116.57M158.06M143.85M210.82M200.14M193.64M275.63M389.69M474.24M469.71M418.16M266.40M441.30M247.46M252.65M
Gross Margin59.18%63.56%71.63%67.77%38.31%42.86%46.50%51.60%48.84%41.07%41.25%44.15%47.03%50.96%49.98%49.72%59.67%52.34%54.20%
Operating Expense19.72M28.38M42.44M52.68M121.38M146.75M118.86M141.64M118.83M145.48M208.22M355.58M493.33M411.69M396.77M479.80M416.31M469.81M412.69M
Operating Income37.06M57.97M114.28M160.44M-4.81M11.31M24.99M69.18M81.31M48.15M67.42M34.11M-19.09M58.02M21.39M-213.41M24.98M-222.35M-160.04M
Operating Margin38.62%42.67%52.23%51.02%-1.58%3.07%8.08%16.93%19.84%10.21%10.09%3.86%-1.89%6.30%2.56%-39.83%3.38%-47.03%-34.34%
EBITDA39.53M63.83M119.25M174.70M23.58M69.61M99.76M124.82M134.47M95.54M118.39M99.79M56.97M98.30M78.83M-143.87M126.28M-148.03M-173.76M
EBITDA Margin41.20%46.98%54.51%55.56%7.75%18.88%32.25%30.55%32.82%20.26%17.72%11.30%5.65%10.67%9.42%-26.85%17.07%-31.31%-37.28%
Net Income34.20M49.52M97.58M139.32M-1.14M22.58M14.85M62.09M68.20M46.16M55.54M13.37M-26.46M9.34M10.99M-187.58M11.53M-216.21M-230.14M
Net Income Margin35.64%36.46%44.60%44.30%-0.37%6.12%4.80%15.20%16.64%9.79%8.31%1.51%-2.62%1.01%1.31%-35.01%1.56%-45.73%-49.37%
R&D---9.36M18.68M14.29M10.44M12.44M9.72M12.32M9.05M28.04M17.20M16.57M14.70M28.44M18.68M19.05M19.10M
R&D as % of Total Revenue---2.98%6.14%3.87%3.38%3.04%2.37%2.61%1.35%3.18%1.71%1.80%1.76%5.31%2.53%4.03%4.10%
Interest Expense246.62K074.89K251.56K394.64K60.52K29.84M212.91K1.26M4.58M8.06M10.41M12.99M19.42M19.50M27.40M25.41M21.37M17.87M
Interest Expense % of Total Revenue0.26%0.00%0.03%0.08%0.13%0.02%9.65%0.05%0.31%0.97%1.21%1.18%1.29%2.11%2.33%5.11%3.44%4.52%3.83%

Balance Sheet

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets141.57M206.34M294.09M1.90B1.96B1.97B1.90B1.93B2.09B2.19B2.24B2.18B2.19B2.61B2.46B2.29B2.17B1.98B1.79B
Total Liabilities25.68M55.93M53.60M76.01M110.77M95.02M94.36M122.49M248.25M316.83M315.31M526.90M592.59M1.01B905.14M932.96M787.60M810.53M869.79M
Total Equity115.89M150.41M240.49M1.83B1.77B1.79B1.73B1.72B1.76B1.80B1.85B1.54B1.50B1.50B1.50B1.32B1.34B1.14B899.71M
Cash60.23M79.99M100.69M1.45B1.09B1.14B1.04B1.04B261.02M164.10M118.39M84.17M165.54M258.27M258.55M269.81M144.40M113.19M59.75M
Total Debt6.00M8.50M8.50M-24.47M---80.00M100.00M100.00M209.50M238.85M648.50M592.80M583.12M501.64M399.73M-
Net Debt-54.23M-71.49M-92.19M-1.45B-1.07B-1.14B-1.04B-1.04B-181.02M-64.10M-18.39M125.33M73.31M390.23M334.25M313.31M357.24M286.55M288.11M

Cash Flow

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow30.59M62.61M93.58M79.89M-100.94M109.46M78.93M73.93M78.30M90.88M18.17M157.66M45.06M-16.74M11.33M29.32M70.69M71.46M121.24M
Investing Cash Flow-11.36M-33.98M-61.04M-174.23M-160.50M-55.97M-56.20M-45.13M-961.65M-213.60M-60.86M175.03M-48.42M-266.48M90.92M13.38M-59.48M-83.91M-
Financing Cash Flow39.68M-18.86M-1.84M1.44B-95.47M-11.00M-65.00M-28.00M49.23M27.18M-3.01M-372.63M-64.13M372.38M-109.61M-36.69M-131.79M-14.06M-
Capital Expenditure20.33M34.10M61.85M114.90M80.56M50.81M56.55M31.04M56.39M41.57M152.85M291.68M130.99M299.57M219.97M45.10M137.56M92.50M92.12M
Free Cash Flow10.26M28.51M31.73M-35.00M-181.50M58.65M22.38M42.89M21.91M49.32M-134.68M-134.02M-85.93M-316.31M-208.64M-15.78M-66.87M-21.04M29.12M
Dividends Paid323.47K11.36M11.84M251.56K60.47M-65.00M28.00M30.77M4.02M3.01M9.68M67.50M22.57M40.68M26.51M24.34M19.87M16.49M
FCF to OCF33.54%45.53%33.91%-43.81%179.81%53.58%28.35%58.02%27.98%54.27%-741.14%-85.01%-190.70%1889.24%-1841.63%-53.81%-94.58%-29.45%24.02%
Dividend Paid to FCF3.15%39.85%37.32%-0.72%-33.32%-290.48%65.28%140.45%8.15%-2.24%-7.22%-78.55%-7.14%-19.50%-168.05%-36.41%-94.43%56.63%

Earnings

Report DateJun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Aug 23, 2016Oct 17, 2016Feb 28, 2017Apr 21, 2017Aug 28, 2017Oct 25, 2017Dec 31, 2017Apr 23, 2018Aug 20, 2018Oct 29, 2018Dec 31, 2018Apr 28, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 25, 2020Aug 25, 2020Oct 30, 2020Dec 31, 2020Apr 28, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------------------------------------------------
EPS Actual0.150.090.110.020.02-0.02-0.030.010.010.030.010.010.020.01-0.010.020.030.030.05-0.020.060.030.080.040.010.020.030.030.040.020.020.040.040.02-0.070.06-0.05-0.01-0.06-0.030.04-0.010.02-0.07-0.060.040.12-0.10-0.09-0.05-0.170.030.00-0.080.07-0.10-0.12-0.05-0.21-0.02-0.10-0.09-0.29-0.03-0.05
Surprise-----------------------------------------------------------------
Timing------------------------Pre-marketPre-marketPre-marketPre-marketPre-marketAfter-hours-After-hoursAfter-hoursPre-market-After-hours-----------------------------

Key Statistics & Ratios

Market Cap2.44B
Enterprise Value2.91B
Trailing P/E0.00
Forward P/E45.25
PEG Ratio0.00
Price / Sales6.46
Price / Book2.88
EPS-0.46
Book Value1.91
Revenue (TTM)378.56M
Gross Profit (TTM)203.63M
EBITDA-78.42M
Profit Margin-55.16%
Operating Margin-54.65%
Return on Equity-21.27%
Return on Assets-4.73%
Shares Outstanding455.12M
Shares Float334.65M
Beta0.27
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20211×
0.02Aug 13, 2021
20191×
0.15Jun 28, 2019
20141×
0.09May 23, 2014
20131×
0.09May 7, 2013
20112×
0.07Oct 14, 20110.07Apr 18, 2011

Stock Splits

  • Sep 30, 201515:10
  • May 23, 201415:10
  • Apr 18, 201120:10